Annual Total Long Term Liabilities
$397.00 K
-$10.38 M-96.31%
31 December 2023
Summary:
INmune Bio annual total long term liabilities is currently $397.00 thousand, with the most recent change of -$10.38 million (-96.31%) on 31 December 2023. During the last 3 years, it has risen by +$271.00 thousand (+215.08%). INMB annual total long term liabilities is now -97.42% below its all-time high of $15.36 million, reached on 31 December 2021.INMB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$284.00 K
-$38.00 K-11.80%
30 September 2024
Summary:
INmune Bio quarterly total long term liabilities is currently $284.00 thousand, with the most recent change of -$38.00 thousand (-11.80%) on 30 September 2024. Over the past year, it has dropped by -$3.33 million (-92.13%). INMB quarterly long term liabilities is now -98.18% below its all-time high of $15.59 million, reached on 30 June 2022.INMB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INMB Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -96.3% | -92.1% |
| 3 y3 years | +215.1% | -98.1% |
| 5 y5 years | +100.0% | +65.6% |
INMB Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -97.4% | +215.1% | -98.2% | at low |
| 5 y | 5 years | -97.4% | -98.2% | +144.8% | |
| alltime | all time | -97.4% | -98.2% |
INmune Bio Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $284.00 K(-11.8%) |
| June 2024 | - | $322.00 K(-10.6%) |
| Mar 2024 | - | $360.00 K(-9.3%) |
| Dec 2023 | $397.00 K(-96.3%) | $397.00 K(-89.0%) |
| Sept 2023 | - | $3.61 M(-39.9%) |
| June 2023 | - | $6.01 M(-28.4%) |
| Mar 2023 | - | $8.40 M(-22.0%) |
| Dec 2022 | $10.77 M(-29.9%) | $10.77 M(-18.4%) |
| Sept 2022 | - | $13.20 M(-15.3%) |
| June 2022 | - | $15.59 M(+0.7%) |
| Mar 2022 | - | $15.48 M(+0.8%) |
| Dec 2021 | $15.36 M | $15.36 M(+5.2%) |
| Sept 2021 | - | $14.61 M(+0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $14.48 M(>+9900.0%) |
| Mar 2021 | - | $116.00 K(-7.9%) |
| Dec 2020 | $126.00 K(-21.3%) | $126.00 K(-7.4%) |
| Sept 2020 | - | $136.00 K(-6.5%) |
| June 2020 | - | $145.40 K(-5.8%) |
| Mar 2020 | - | $154.30 K(-3.7%) |
| Dec 2019 | $160.20 K(>+9900.0%) | $160.20 K(-6.6%) |
| Sept 2019 | - | $171.50 K(-3.2%) |
| June 2019 | - | $177.10 K(>+9900.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00 |
| Dec 2016 | $0.00 | - |
FAQ
- What is INmune Bio annual total long term liabilities?
- What is the all time high annual total long term liabilities for INmune Bio?
- What is INmune Bio annual total long term liabilities year-on-year change?
- What is INmune Bio quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for INmune Bio?
- What is INmune Bio quarterly long term liabilities year-on-year change?
What is INmune Bio annual total long term liabilities?
The current annual total long term liabilities of INMB is $397.00 K
What is the all time high annual total long term liabilities for INmune Bio?
INmune Bio all-time high annual total long term liabilities is $15.36 M
What is INmune Bio annual total long term liabilities year-on-year change?
Over the past year, INMB annual total long term liabilities has changed by -$10.38 M (-96.31%)
What is INmune Bio quarterly total long term liabilities?
The current quarterly long term liabilities of INMB is $284.00 K
What is the all time high quarterly long term liabilities for INmune Bio?
INmune Bio all-time high quarterly total long term liabilities is $15.59 M
What is INmune Bio quarterly long term liabilities year-on-year change?
Over the past year, INMB quarterly total long term liabilities has changed by -$3.33 M (-92.13%)